Doximity, Inc. (NASDAQ:DOCS) Stake Cut by HighTower Advisors LLC

HighTower Advisors LLC lowered its stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 61.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 25,054 shares of the company's stock after selling 39,677 shares during the quarter. HighTower Advisors LLC's holdings in Doximity were worth $1,091,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Farther Finance Advisors LLC grew its position in Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock valued at $34,000 after acquiring an additional 603 shares during the period. Blue Trust Inc. lifted its stake in shares of Doximity by 621.4% in the 2nd quarter. Blue Trust Inc. now owns 1,385 shares of the company's stock valued at $37,000 after purchasing an additional 1,193 shares in the last quarter. Quarry LP grew its holdings in shares of Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company's stock worth $45,000 after purchasing an additional 131,253 shares during the period. First Horizon Advisors Inc. increased its position in Doximity by 80.0% during the 2nd quarter. First Horizon Advisors Inc. now owns 1,710 shares of the company's stock worth $48,000 after purchasing an additional 760 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in Doximity by 40.1% in the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company's stock valued at $63,000 after buying an additional 412 shares during the period. 87.19% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on DOCS shares. Canaccord Genuity Group reaffirmed a "hold" rating and set a $60.00 price target (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Robert W. Baird lifted their target price on shares of Doximity from $41.00 to $45.00 and gave the company an "outperform" rating in a report on Tuesday, September 17th. Raymond James reiterated an "outperform" rating and issued a $65.00 price target (up from $37.00) on shares of Doximity in a report on Friday, November 8th. KeyCorp raised Doximity from a "sector weight" rating to an "overweight" rating and set a $70.00 price objective on the stock in a research report on Friday, November 8th. Finally, Evercore ISI upped their target price on Doximity from $34.00 to $45.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. Twelve investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $52.44.

Doximity Trading Down 1.0 %

NASDAQ DOCS traded down $0.51 during trading hours on Wednesday, reaching $52.19. 2,269,827 shares of the company traded hands, compared to its average volume of 1,750,335. The stock has a market capitalization of $9.74 billion, a PE ratio of 59.99, a PEG ratio of 4.16 and a beta of 1.40. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75. The company has a 50 day moving average of $48.58 and a two-hundred day moving average of $38.46.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.